Royal Biologics

Innovating orthobiologics and wound care solutions for enhanced healing

placeJersey City, New Jersey, United States calendar_todayFounded 2015 groups16 employees language royalbiologics.com

Innovation

3 patent families (1 granted) — focus: Human necessities, Operations & transport; filing pace slowing. Cited 85 times.

YearFilings
20171
20181
20191
20201
20211
20221
20232
20251

Social engagement

Social engagement: 4.2K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record; lead investors include Granite Creek Capital Partners.

Investor typeCountShare
Private equity1100%

Recent activity

19 May 2026
Product launch
Magnus® Ultra
23 Apr 2026
Product launch
Fibrinet® PRF Wound Matrix
Coming soon